Showing 351-360 of 1857 results for "".
Rosacea Update: A Closer Look at Zilxi
https://practicaldermatology.com/columns/clinical-focus-1/rosacea-update-a-closer-look-at-zilxi/23339/Inside the approval of Zilxi for moderate-to-severe facial papulopustular rosacea.Behind the Sunscreen Recall
https://practicaldermatology.com/topics/skin-cancer-photoprotection/behind-the-sunscreen-recall/23557/Use the latest media buzz as an excuse to educate.Are Sunscreens and Cosmetics Really Safe?
https://practicaldermatology.com/topics/skin-cancer-photoprotection/are-sunscreens-and-cosmetics-really-safe/23558/There is basis for some of the concern around skincare ingredients, but dermatologists have the knowledge and expertise to guide patients to products that are safe.Collagen in Atopic Dermatitis
https://practicaldermatology.com/topics/atopic-dermatitis/collagen-atopic-dermatitis/27167/Kripa Ahuja, MS, and Peter Lio, MD, review a 2024 study from Szalsus et al. looking at the role of collagens in atopic dermatitis (AD).The Clinical Significance of Gene Expression Profile Testing for Melanoma
https://practicaldermatology.com/topics/practice-management/the-clinical-significance-of-gene-expression-profile-testing-for-melanoma/20647/Accumulated evidence on GEP Classification suggests that it provides clinically relevant information that can influence patient management for the better.Inside the Minds of Acne Patients
https://practicaldermatology.com/columns/clinical-focus-1/inside-the-minds-of-acne-patients/23634/Recommendations on how to start developing a treatment plan with its roots in the psychology of the acne patient.Herbals in the Holistic Treatment of Psoriasis
https://practicaldermatology.com/topics/psoriasis/herbals-in-the-holistic-treatment-of-psoriasis/21055/Dermatologists must be aware of the herbal supplements patients may take and their potential effects.Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments/21928/Case Report: First Reported Case of Facial Rash After Dupilumab Therapy; Call for Abstracts
https://practicaldermatology.com/youngmd-connect/resident-resource-center/case-report-first-reported-case-of-facial-rash-after-dupilumab-therapy-call-for-abstracts/20499/First Reported Case of Red Face Response to Tralokinumab in the United States
https://practicaldermatology.com/issues/september-2025/first-reported-case-of-red-face-response-to-tralokinumab-in-the-united-states/37639/The chronic nature of atopic dermatitis (AD), which currently affects approximately 10.8% of children and 7.3% of adults in the United States,1 makes long-term management challenging.